|By Marketwired .||
|June 25, 2014 07:36 PM EDT||
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/25/14 -- Pyng Medical Corp. (TSX VENTURE: PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical care personnel, announces that its new FASTResponder Sternal IO and T-PODResponder Pelvic Stabilization Device were both awarded with the Hot Products title for 2014 by the Journal of Emergency Medical Services (JEMS).
"Our team at Pyng worked hard to develop sternal IO and pelvic stabilization products to meet the specific needs of civilian EMS personnel," said Pyng CEO Mark Hodge. "We're thrilled that such a respected organization as JEMS has validated these efforts and endorsed FASTResponder and T-PODResponder as two of the top products for the EMS market."
FASTResponder is Pyng's newest sternal intraosseous device (sternal IO) that gives emergency medical services and emergency hospital personnel the critical ability to quickly establish vascular access, and rapidly and easily deliver emergency fluids and medications into the vascular system when traditional intravenous access fails.
Pyng Medical is the pioneer in sternal intraosseous infusion technology, having launched FAST1, the first FDA-cleared IO system designed specifically for use in the sternum during adult and adolescent emergency intervention. FAST1 has been trusted and used by military and combat personnel for more than 14 years. FASTResponder includes all the trusted and proven features of FAST1, but has been modified to specifically meet the needs of civilian emergency medical services and hospital critical care personnel.
T-PODResponder is Pyng's newest pelvic stabilization device from Pyng Medical. Developed for first responders, T-PODResponder is specifically designed to be quickly applied in the field by one person using an easy-to-tighten pulley system. With a highly flexible design, T-PODResponder is small and compact, is one-size-fits-all, and can remain on through MRI, X-Ray and CT scans.
According to the JEMS Hot Products website, "To earn the coveted title of a JEMS Hot Product, a product has to be not only innovative, but practical. Each judge reviewed products designed to not only improve your ability to deliver optimal emergency medical care to sick and injured patients, but also allow you to do it safely, more efficiently and with enhanced comfort for the patient. These contenders were rated on their originality, functionality, ease of use and need in the EMS setting."
To learn more about the JEMS Hot Products Awards, download the PDF at http://www.jems.com/sites/default/files/HotProdcuts_0.pdf or visit the JEMS Hot Products issue web page at: http://www.jems.com/magazines/2014/june.
-- For more information on FASTResponder, visit: http://go.pyng.com/fastresponder -- For more information on T-PODResponder, visit: http://go.pyng.com/t- podresponder
About Pyng Medical Corp.
Pyng Medical Corp. engineers and markets award-winning trauma and resuscitation products for front-line critical care personnel world-wide. Pyng's product portfolio includes innovative sternal intraosseous (sternal IO) pelvic stabilization and tourniquet devices specifically designed and customized for both the military and civilian markets. With growing markets in North America, Europe and Asia, Pyng develops user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.
Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.
Pyng Medical Corp.
Chief Financial Officer
(604) 303-7964 x219